80 / 1542
Tvilum
et al
., Acta Oncologica 2015
I
N=104 (N)SCLC patients, 52 ART with PTV margin 4mm for primary
tumor, 52 bone match with 10mm PTV margin
I
Follow-up CT scans in three-monthly intervals
I
Median follow-up 16 months (3-35 months), treatment adaptation in
12/52 ART-patients
I
Locoregional recurrence 35% ART, 53% in non-ART (
p
=0.05), marginal
recurrence in 1
versus
4 patients
I
Overall survival: 10
versus
8 months
I
Grade ≥ 2 pneumonitis: 18%
versus
22% (
p
=0.6)
First clinical results following adaptive RT in
NSCLC